Search

You searched for "blind"

3642 results found

RPE use similar pathway to regulatory T cells to inhibit immune response

1 December 2014 | | Retina / Uvea / Vitreous | CD4 cells, CD73, RPE, inhibition
Retinal pigment epithelial (RPE) cells form an important part of the blood-retinal barrier that protects the neuronal cells responsible for sight. RPE cells are involved in innate and adaptive immune responses via expression of surface molecules and release of cytokines....

Gender variations in retinopathy

1 August 2014 | | Retina / Uvea / Vitreous | blood pressure, cardiovascular disease, epidemiology, hypertension, microalbuminuria, prevalence, retinopathy, risk factors, urinary albumin excretion
The Tromso Eye Study is a substudy of the Tromso Study; a population based longitudinal study based in Norway. The extensive 5869 participants had no diabetes and were aged between 30-87 years. Retinal images from both eyes were taken using...

Topical doxycycline for corneal neovascularisation

1 June 2014 | | Cornea / External Eye Disease, Ophthalmology
Six eyes with corneal vascularisation were treated with 1% topical doxycycline, four times a day for three weeks. The patients were reviewed at various intervals over a period of one year. The eyes selected had neovascularisation secondary to a variety...

Arterial stiffness and PEX

1 April 2014 | | Glaucoma
The authors describe a study of 25 newly diagnosed patients with pseudoexfoliation glaucoma (PEX) and 25 controls to evaluate carotid femoral pulse wave velocity (CF-PWV) values. The CF-PWV was assessed using a noninvasive device by measuring the pulse transmit time...

Diabetic retinopathy and body fat distribution and adipokine secretion in type 2 diabetics

1 April 2014 | | Ophthalmology, Retina / Uvea / Vitreous
The major risk factors for diabetic retinopathy (DR) in patients with diabetes are poor glycaemic or blood pressure control, duration of diabetes and nephropathy related to the severity of DR. Several studies suggest that DR is associated with visceral fat...

Erythropoietin in healing corneal epithelial defects in rabbits

1 December 2013 | | Cornea / External Eye Disease
Corneal epithelial defects heal slowly in patients with diabetes, limbal stem cell deficiency and severe chemical burns. Erythropoietin is a glycoprotein hormone that promotes red blood cell proliferation and inhibits apoptosis of erythroid progenitors as well as nonhematopoietic cells. In...

Transient thickening of the macular retinal nerve fibre layer in acute optic neuritis

1 December 2022 | | Neuro-Ophthalmology | Optic neuritis, axonal degeneration, neurofilament protein, retina, tissue
Acute optic neuritis (ON) causes axonal degeneration, which can be quantified from the blood by neurofilament protein (Nf) levels. Within about three months, atrophy of the retinal nerve fibre layer (RNFL) follows. However, it remains challenging to explain why there...

Review of non-arteritic anterior ischaemic optic neuropathy

1 October 2016 | | Neuro-Ophthalmology | Neuroprotection, optic nerve ischemia, optic nerve vasculature, primate models, rodent models
This article reviews the risk factors, clinical presentation and therapies that have been investigated for non-arteritic anterior ischaemic optic neuropathy (NAAION). Additionally, it provides an update from recent rodent and primate models, offering a new insight into the pathophysiology of...

CHEC ‘Re:Sets’ sights on patient outcomes and growth ambitions

21 September 2023 | CHEC, NHS, infrastructure, Industry
CHEC, one of the largest providers of community-based ophthalmology services in the UK, has launched an enhanced go-to-market strategy that will better align its service offerings and provision with the NHS’ evolving needs.

App and web service recommendations

1 April 2019 | | Ophthalmology, Optometry
This article offers some app and web service suggestions. A few are new and others well established, but all offer useful features. Messaging for teams Many businesses provide their employees with instant messaging services to allow calling, messaging and collaboration....

Landmark review of glaucoma treatment and research published by Moorfields-led team

22 September 2023 | moorfields, glaucoma, research, developments, guzzard, the eagle, MIGS, Omni
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

Corporate M&A pace gathers momentum

1 October 2019 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...